• News
  • Finance

Bristol-Myers Falls After Drugmaker Cites Drug-Trial Questions

Jan. 24 (Bloomberg) -- Bristol-Myers Squibb Co. plunged the most in 17 months after the drugmaker said it wasn’t ready to move ahead with a study of a combination cancer treatment that includes the company’s top prospect.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!